Awards for Excellence 2020
|
|
In November 2019, AbbVie priced a $30 billion, 10-tranche bond that was the fourth-largest corporate bond ever. The trade, which backed AbbVie’s acquisition of Allergan, wrapped up an extraordinary financing package by Morgan Stanley.
In a year of startling success, it is just the most striking reason why the firm is North America’s best bank for financing.
The AbbVie bond priced just eight days before the formal completion of another mega-deal, the $74 billion acquisition of Celgene by Bristol-Myers Squibb, the biggest M&A deal ever in the healthcare sector.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
